{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:46:11Z","timestamp":1791179171933,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T00:00:00Z","timestamp":1428364800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1282-1","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T12:08:22Z","timestamp":1428322102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Tenovin-6-mediated inhibition of SIRT1\/2 induces apoptosis in acute lymphoblastic leukemia (ALL) cells and eliminates ALL stem\/progenitor cells"],"prefix":"10.1186","volume":"15","author":[{"given":"Yanli","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,7]]},"reference":[{"issue":"6","key":"1282_CR1","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1016\/S1470-2045(12)70580-6","volume":"14","author":"D Bhojwani","year":"2013","unstructured":"Bhojwani D, Pui CH. Relapsed childhood acute lymphoblastic leukaemia. Lancet Oncol. 2013;14(6):e205\u2013217.","journal-title":"Lancet Oncol"},{"issue":"5","key":"1282_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s40265-013-0026-2","volume":"73","author":"KJ August","year":"2013","unstructured":"August KJ, Narendran A, Neville KA. Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions. Drugs. 2013;73(5):439\u201361.","journal-title":"Drugs"},{"issue":"34","key":"1282_CR3","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1200\/JCO.2012.48.5292","volume":"31","author":"A Trinquand","year":"2013","unstructured":"Trinquand A, Tanguy-Schmidt A, Ben Abdelali R, Lambert J, Beldjord K, Lengline E, et al. Toward a NOTCH1\/FBXW7\/RAS\/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study. J Clin Oncol. 2013;31(34):4333\u201342.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1282_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0037-1963(03)00195-1","volume":"40","author":"AA Ferrando","year":"2003","unstructured":"Ferrando AA, Look AT. Gene expression profiling in T-cell acute lymphoblastic leukemia. Semin Hematol. 2003;40(4):274\u201380.","journal-title":"Semin Hematol"},{"issue":"2","key":"1282_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/ng.2874","volume":"46","author":"E Papaemmanuil","year":"2014","unstructured":"Papaemmanuil E, Rapado I, Li Y, Potter NE, Wedge DC, Tubio J, et al. RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia. Nat Genet. 2014;46(2):116\u201325.","journal-title":"Nat Genet"},{"issue":"3","key":"1282_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4161\/epi.27585","volume":"9","author":"Z Chatterton","year":"2014","unstructured":"Chatterton Z, Morenos L, Mechinaud F, Ashley DM, Craig JM, Sexton-Oates A, et al. Epigenetic deregulation in pediatric acute lymphoblastic leukemia. Epigenetics. 2014;9(3):459\u201367.","journal-title":"Epigenetics"},{"issue":"4","key":"1282_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.4155\/fmc.12.6","volume":"4","author":"S Rangwala","year":"2012","unstructured":"Rangwala S, Zhang C, Duvic M. HDAC inhibitors for the treatment of cutaneous T-cell lymphomas. Future Med Chem. 2012;4(4):471\u201386.","journal-title":"Future Med Chem"},{"issue":"12","key":"1282_CR8","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nrd4154","volume":"12","author":"JW Hojfeldt","year":"2013","unstructured":"Hojfeldt JW, Agger K, Helin K. Histone lysine demethylases as targets for anticancer therapy. Nat Rev Drug Discov. 2013;12(12):917\u201330.","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"1282_CR9","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/bies.201000061","volume":"32","author":"C Mund","year":"2010","unstructured":"Mund C, Lyko F. Epigenetic cancer therapy: Proof of concept and remaining challenges. Bioessays. 2010;32(11):949\u201357.","journal-title":"Bioessays"},{"issue":"5666","key":"1282_CR10","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1126\/science.1094637","volume":"303","author":"A Brunet","year":"2004","unstructured":"Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science. 2004;303(5666):2011\u20135.","journal-title":"Science"},{"issue":"13","key":"1282_CR11","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1128\/MCB.02279-06","volume":"27","author":"L Qiang","year":"2007","unstructured":"Qiang L, Wang H, Farmer SR. Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase Ero1-L alpha. Mol Cell Biol. 2007;27(13):4698\u2013707.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"1282_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.bbrc.2008.06.045","volume":"373","author":"K Kojima","year":"2008","unstructured":"Kojima K, Ohhashi R, Fujita Y, Hamada N, Akao Y, Nozawa Y, et al. A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells. Biochem Biophys Res Commun. 2008;373(3):423\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"1282_CR13","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1158\/1541-7786.MCR-07-2130","volume":"6","author":"XJ Liang","year":"2008","unstructured":"Liang XJ, Finkel T, Shen DW, Yin JJ, Aszalos A, Gottesman MM. SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism. Mol Cancer Res. 2008;6(9):1499\u2013506.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"1282_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0092-8674(01)00524-4","volume":"107","author":"J Luo","year":"2001","unstructured":"Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell. 2001;107(2):137\u201348.","journal-title":"Cell"},{"issue":"2","key":"1282_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0092-8674(01)00527-X","volume":"107","author":"H Vaziri","year":"2001","unstructured":"Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. 2001;107(2):149\u201359.","journal-title":"Cell"},{"issue":"5","key":"1282_CR16","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S1097-2765(04)00094-2","volume":"13","author":"HY Cohen","year":"2004","unstructured":"Cohen HY, Lavu S, Bitterman KJ, Hekking B, Imahiyerobo TA, Miller C, et al. Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell. 2004;13(5):627\u201338.","journal-title":"Mol Cell"},{"issue":"9","key":"1282_CR17","first-page":"2473","volume":"116","author":"J Nakae","year":"2006","unstructured":"Nakae J, Cao Y, Daitoku H, Fukamizu A, Ogawa W, Yano Y, et al. The LXXLL motif of murine forkhead transcription factor FoxO1 mediates Sirt1-dependent transcriptional activity. J Clin Invest. 2006;116(9):2473\u201383.","journal-title":"J Clin Invest"},{"issue":"2","key":"1282_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ccr.2011.12.020","volume":"21","author":"L Li","year":"2012","unstructured":"Li L, Wang L, Wang Z, Ho Y, McDonald T, Holyoake TL, et al. Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib. Cancer Cell. 2012;21(2):266\u201381.","journal-title":"Cancer Cell"},{"issue":"8","key":"1282_CR19","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1182\/blood-2011-06-361691","volume":"119","author":"H Yuan","year":"2012","unstructured":"Yuan H, Wang Z, Li L, Zhang H, Modi H, Horne D, et al. Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis. Blood. 2012;119(8):1904\u201314.","journal-title":"Blood"},{"issue":"6","key":"1282_CR20","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1158\/0008-5472.CAN-09-3950","volume":"70","author":"Y Jin","year":"2010","unstructured":"Jin Y, Lu Z, Ding K, Li J, Du X, Chen C, et al. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species. Cancer Res. 2010;70(6):2516\u201327.","journal-title":"Cancer Res"},{"issue":"5","key":"1282_CR21","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1158\/1078-0432.CCR-08-2141","volume":"15","author":"X Shi","year":"2009","unstructured":"Shi X, Jin Y, Cheng C, Zhang H, Zou W, Zheng Q, et al. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation. Clin Cancer Res. 2009;15(5):1686\u201397.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"1282_CR22","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1158\/1078-0432.CCR-11-1971","volume":"18","author":"Y Wu","year":"2012","unstructured":"Wu Y, Chen C, Sun X, Shi X, Jin B, Ding K, et al. Cyclin-dependent kinase 7\/9 inhibitor SNS-032 abrogates FIP1-like-1 platelet-derived growth factor receptor alpha and bcr-abl oncogene addiction in malignant hematologic cells. Clin Cancer Res. 2012;18(7):1966\u201378.","journal-title":"Clin Cancer Res"},{"issue":"18","key":"1282_CR23","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1016\/j.yexcr.2006.08.003","volume":"312","author":"G Zeng","year":"2006","unstructured":"Zeng G, Apte U, Micsenyi A, Bell A, Monga SP. Tyrosine residues 654 and 670 in beta-catenin are crucial in regulation of Met-beta-catenin interactions. Exp Cell Res. 2006;312(18):3620\u201330.","journal-title":"Exp Cell Res"},{"issue":"5","key":"1282_CR24","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ccr.2008.03.004","volume":"13","author":"S Lain","year":"2008","unstructured":"Lain S, Hollick JJ, Campbell J, Staples OD, Higgins M, Aoubala M, et al. Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator. Cancer Cell. 2008;13(5):454\u201363.","journal-title":"Cancer Cell"},{"key":"1282_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1101\/sqb.2008.73.035","volume":"73","author":"R Nusse","year":"2008","unstructured":"Nusse R, Fuerer C, Ching W, Harnish K, Logan C, Zeng A, et al. Wnt signaling and stem cell control. Cold Spring Harb Symp Quant Biol. 2008;73:59\u201366.","journal-title":"Cold Spring Harb Symp Quant Biol."},{"issue":"20","key":"1282_CR26","doi-asserted-by":"publisher","first-page":"9216","DOI":"10.1073\/pnas.0911325107","volume":"107","author":"KR Holloway","year":"2010","unstructured":"Holloway KR, Calhoun TN, Saxena M, Metoyer CF, Kandler EF, Rivera CA, et al. SIRT1 regulates Dishevelled proteins and promotes transient and constitutive Wnt signaling. Proc Natl Acad Sci U S A. 2010;107(20):9216\u201321.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"1282_CR27","doi-asserted-by":"publisher","first-page":"6768","DOI":"10.1128\/MCB.21.20.6768-6781.2001","volume":"21","author":"E Sadot","year":"2001","unstructured":"Sadot E, Geiger B, Oren M, Ben-Ze'ev A. Down-regulation of beta-catenin by activated p53. Mol Cell Biol. 2001;21(20):6768\u201381.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"1282_CR28","doi-asserted-by":"publisher","first-page":"djt373","DOI":"10.1093\/jnci\/djt373","volume":"106","author":"BS Moon","year":"2014","unstructured":"Moon BS, Jeong WJ, Park J, Kim TI, Min Do S, Choi KY. Role of Oncogenic K-Ras in Cancer Stem Cell Activation by Aberrant Wnt\/beta-Catenin Signaling. J Natl Cancer Inst. 2014;106(2):djt373.","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"1282_CR29","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1182\/blood-2008-04-154187","volume":"113","author":"CV Cox","year":"2009","unstructured":"Cox CV, Diamanti P, Evely RS, Kearns PR, Blair A. Expression of CD133 on leukemia-initiating cells in childhood ALL. Blood. 2009;113(14):3287\u201396.","journal-title":"Blood"},{"issue":"2","key":"1282_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.7150\/ijbs.5.147","volume":"5","author":"CX Deng","year":"2009","unstructured":"Deng CX. SIRT1, is it a tumor promoter or tumor suppressor? Int J Biol Sci. 2009;5(2):147\u201352.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"1282_CR31","doi-asserted-by":"publisher","first-page":"e2020","DOI":"10.1371\/journal.pone.0002020","volume":"3","author":"R Firestein","year":"2008","unstructured":"Firestein R, Blander G, Michan S, Oberdoerffer P, Ogino S, Campbell J, et al. The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One. 2008;3(4):e2020.","journal-title":"PLoS One"},{"issue":"8","key":"1282_CR32","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1158\/0008-5472.CAN-05-3617","volume":"66","author":"B Heltweg","year":"2006","unstructured":"Heltweg B, Gatbonton T, Schuler AD, Posakony J, Li H, Goehle S, et al. Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res. 2006;66(8):4368\u201377.","journal-title":"Cancer Res"},{"issue":"5","key":"1282_CR33","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1158\/0008-5472.CAN-08-3365","volume":"69","author":"T Liu","year":"2009","unstructured":"Liu T, Liu PY, Marshall GM. The critical role of the class III histone deacetylase SIRT1 in cancer. Cancer Res. 2009;69(5):1702\u20135.","journal-title":"Cancer Res"},{"issue":"10","key":"1282_CR34","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/sj.leu.2403910","volume":"19","author":"CA Bradbury","year":"2005","unstructured":"Bradbury CA, Khanim FL, Hayden R, Bunce CM, White DA, Drayson MT, et al. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia. 2005;19(10):1751\u20139.","journal-title":"Leukemia"},{"issue":"14","key":"1282_CR35","doi-asserted-by":"publisher","first-page":"6612","DOI":"10.1158\/0008-5472.CAN-07-0085","volume":"67","author":"DM Huffman","year":"2007","unstructured":"Huffman DM, Grizzle WE, Bamman MM, Kim JS, Eltoum IA, Elgavish A, et al. SIRT1 is significantly elevated in mouse and human prostate cancer. Cancer Res. 2007;67(14):6612\u20138.","journal-title":"Cancer Res"},{"key":"1282_CR36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1471-2164-7-90","volume":"7","author":"H Ozdag","year":"2006","unstructured":"Ozdag H, Teschendorff AE, Ahmed AA, Hyland SJ, Blenkiron C, Bobrow L, et al. Differential expression of selected histone modifier genes in human solid cancers. BMC Genomics. 2006;7:90.","journal-title":"BMC Genomics."},{"issue":"2","key":"1282_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00403-006-0725-6","volume":"299","author":"Y Hida","year":"2007","unstructured":"Hida Y, Kubo Y, Murao K, Arase S. Strong expression of a longevity-related protein, SIRT1, in Bowen's disease. Arch Dermatol Res. 2007;299(2):103\u20136.","journal-title":"Arch Dermatol Res"},{"issue":"22","key":"1282_CR38","doi-asserted-by":"publisher","first-page":"10183","DOI":"10.1158\/0008-5472.CAN-05-2002","volume":"65","author":"F Chu","year":"2005","unstructured":"Chu F, Chou PM, Zheng X, Mirkin BL, Rebbaa A. Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1. Cancer Res. 2005;65(22):10183\u20137.","journal-title":"Cancer Res"},{"key":"1282_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1476-4598-5-67","volume":"5","author":"G Liu","year":"2006","unstructured":"Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer. 2006;5:67.","journal-title":"Mol Cancer."},{"issue":"197","key":"1282_CR40","doi-asserted-by":"publisher","first-page":"ra71","DOI":"10.1126\/scisignal.2001744","volume":"4","author":"NH Kim","year":"2011","unstructured":"Kim NH, Kim HS, Kim NG, Lee I, Choi HS, Li XY, et al. p53 and microRNA-34 are suppressors of canonical Wnt signaling. Sci Signal. 2011;4(197):ra71.","journal-title":"Sci Signal"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1282-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1282-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1282-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1282-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T10:24:44Z","timestamp":1630578284000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1282-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1282"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1282-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,7]]},"assertion":[{"value":"8 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"226"}}